Molbio Diagnostics

Pioneering point-of-care molecular diagnostics with Truenat | Serving 85+ countries | Enabling early detection everywhere

[Molbio Diagnostics @MolbioDx]

In India, a woman dies of cervical cancer roughly every seven minutes. A new case is diagnosed every four. It is one of the most preventable cancers we have.

This International Day of Action for Women's Health, Dr. Kuldeep Singh Sachdeva ( @DrKSachdeva ) , President & CMO, Partnerships and Advocacy, Molbio Diagnostics, writes on why protecting the next generation isn't enough, and what the women at risk today still need.

Read Here: https://t.co/kcDftFz1Hv

#WomensHealth #CervicalCancer #Truenat #MolbioDiagnostics

[Molbio Diagnostics @MolbioDx]

On Mother's Day, 13 women in Margao were screened for breast health using iBreastExam - painless, portable, and for many, a first.

One positive finding flagged. One more reason early screening matters.

Thank you to the Rotary Club of Margao Sunrise and Healing Touch Centre for championing women's health in their community.

#BreastHealth #iBreastExam #EarlyDetection #WomensHealth #MolbioDiagnostics #BreastCancerScreening

@UELifeSciences @iBreastExam

[Molbio Diagnostics @MolbioDx]

Molecular TB testing was, for too long, priced out of the settings that needed it most. That is changing - and Indian innovation is at the centre of it.

Read the full article in the Times of India: https://t.co/bMgCLgvKAE

#EndTB #Truenat #MolbioDiagnostics

[Molbio Diagnostics @MolbioDx]

Tuberculosis remains a major public health challenge in the Philippines. Spread across over 7,000 islands, access to timely diagnosis remains one of the most significant barriers.

Since its introduction in 2021, #Truenat has become part of the country’s response—bringing testing closer to where it’s needed most.

We spoke to 𝗧𝗲𝗼𝗱𝗼𝗿𝗼 𝗝. 𝗛𝗲𝗿𝗯𝗼𝘀𝗮, 𝗦𝗲𝗰𝗿𝗲𝘁𝗮𝗿𝘆 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵, 𝗣𝗵𝗶𝗹𝗶𝗽𝗽𝗶𝗻𝗲𝘀, to understand the role it is playing in decentralising access to care.

Because in a country defined by distance, access isn’t just important—it’s everything.

#YesWeCanEndTB #decentralisedcare #Philippines #PointofCare #AccessibleDiagnostics

[Molbio Diagnostics @MolbioDx]

#Tuberculosis remains one of India’s most pressing public health challenges.

But the response is changing—faster, stronger, more accessible.

Since 2015, TB incidence has declined by 21% (WHO Global TB Report 2025), nearly twice the global average, driven by frontline efforts.

This film traces that shift—and what it takes to sustain it.

#Molbio was founded with the vision of decentralising diagnostics and expanding healthcare access. And we are proud to stand alongside the medical community working every day to move India closer to eliminating TB.

#WorldTBDay #EndTB #YesWeCanEndTB #StopTB #MolbioDiagnostics #Truenat

[Molbio Diagnostics @MolbioDx]

Truenat® MTB-RIF Dx has received regulatory approval from ANVISA and is now authorised for commercialisation in Brazil.

With over 110,000 TB cases reported annually in the country, timely detection of rifampicin resistance is essential for guiding treatment and limiting drug-resistant TB.

ANVISA registration enables rapid, decentralised detection, strengthening TB diagnostics and supporting earlier treatment decisions.

#Truenat #Tuberculosis #TBControl #Brazil #ANVISA #MolbioDiagnostics

[Molbio Diagnostics @MolbioDx]

Molbio Diagnostics will be in Baku, Azerbaijan on 13 March 2026 for Innovative Approaches in Tuberculosis Control, bringing together clinicians, policymakers, and diagnostics leaders to discuss the future of TB control.

Amin Belal, General Manager – Europe & Central Asia, International Sales, Molbio Diagnostics Ltd., will join a panel discussion on Innovation & Collaboration in Healthcare: Exploring a New Era in the Fight Against Tuberculosis.

#Tuberculosis #TBControl #EndTB #GlobalHealth #Diagnostics #MolbioDiagnostics

[Molbio Diagnostics @MolbioDx]

Behind every Truenat device is a team working to advance accessible diagnostics. Among them are the women of Molbio Diagnostics—engineers, scientists, and professionals helping bring quality healthcare closer to communities.

This #InternationalWomensDay, we hear from some of the women shaping these technologies.

Their work strengthens healthcare every day. Today simply gives us a moment to recognise it.

#IWD2026 #WomenInSTEM #WomenInScience #MolbioDiagnostics #Truenat

[Molbio Diagnostics @MolbioDx]

Access to healthcare should not depend on freedom of movement.

Since Mar 2024, Truenat TB platforms in Kenya’s prison system have conducted 3,300+ tests with same-day results—strengthening timely TB detection in custodial settings.

#Truenat #MolbioDiagnostics #TB #PointOfCare #PublicHealth

[Molbio Diagnostics @MolbioDx]

Holi is a celebration of renewal, togetherness, and new beginnings. Wishing everyone warmth, joy, and good health from all of us at Molbio Diagnostics.

#Holi2026 #MolbioDiagnostics #Truenat #PointOfCare #AccessibleDiagnostics #HoliCelebration

[Molbio Diagnostics @MolbioDx]

On Day 2 of NICON 2026, Dr Kuldeep Singh Sachdeva will lead a session on TB epidemiology and transmission dynamics.

As India’s TB and respiratory health community gathers in New Delhi, the discussion will focus on understanding how transmission patterns shape control strategies, programme design, and response on the ground.

If you’re attending NICON, join the session.

#NICON2026 #Tuberculosis #PublicHealth #MolbioDiagnostics

[Molbio Diagnostics @MolbioDx]

3/3

[Molbio Diagnostics @MolbioDx]

From breaking barriers to building solutions — this #InternationalDayOfWomenAndGirlsInScience, we honour Indian women whose contributions to medical science and diagnostics changed the way healthcare reaches communities, today.

#MolbioDiagnostics #WomenInSTEM #HealthcareEquity #PointofCare #Truenat

1/3

[Molbio Diagnostics @MolbioDx]

2/3

[Molbio Diagnostics @MolbioDx]

We’re headed to WHX Labs Dubai 2026.

Meet the team from Molbio Diagnostics from 10–13 February at Sheikh Saeed Arena, Dubai World Trade Centre, Stall #SAE01, and explore our diagnostic solutions across molecular testing, digital pathology, radiology and breast health screening.

Mani Subramani, Product Group Manager, invites you to stop by and connect with us in Dubai.

#WHXLabsDubai #MolbioDiagnostics #Diagnostics #PointOfCare #Truenat

[Molbio Diagnostics @MolbioDx]

Nipah virus continues to affect families and communities in parts of South and Southeast Asia.

With no specific treatment or vaccine, early diagnosis is the most effective way to reduce its impact.

Truenat® Nipah enables real-time PCR testing at or near the point of care—bringing diagnostics closer to outbreak zones and supporting faster response.

#NipahVirus #TruenatNipah #DiagnosticsThatMatter #CommunityHealth #MolbioDiagnostics #Truenat #PointofCare

[Molbio Diagnostics @MolbioDx]

Molbio Diagnostics will be at WHX Labs Dubai 2026.

From 10–13 February at Sheikh Saeed Arena, Dubai World Trade Centre, we will be showcasing diagnostic solutions across care pathways — spanning molecular diagnostics, digital pathology, radiology and breast health screening.

Visit us at Stall # SA.E01 to meet our teams and learn how Molbio, along with Prognosys Medical System , UE LifeSciences and OptraSCAN , is working towards decentralising diagnosis for every community.

@WHXDubai | @UELifeSciences | @OptraSCAN

#WHXLabsDubai #MolbioDiagnostics #Diagnostics #MolecularDiagnostics #DigitalPathology #RadiologyAI #BreastHealth #PointOfCare

[Molbio Diagnostics @MolbioDx]

2/2

[Molbio Diagnostics @MolbioDx]

Molbio will be present at ROCNMC 2026, ACCLMPCON 2026, and ESMO Summit Africa 2026, engaging with clinicians, laboratory professionals, and oncology specialists across care settings.

We’ll be showcasing Truenat, ProRad Atlas, OptraScan, and iBreastExam, and discussing how decentralised diagnostics can support timely, evidence-based clinical decisions.

Meet our teams at the booth.

#MolbioDiagnostics #Truenat #MolecularDiagnostics #Oncology #LabMedicine #GlobalHealth

1/2